Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

The volume has dried up from the previously high l

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30066
Posted On: 11/09/2015 10:18:04 AM
Posted By: All Aboard
Re: Bornet #21307
The volume has dried up from the previously high levels.

But I disagree with some of your post.

The Series H were covered under the shelf registration (i.e., the S-3). That was for $150 million.

The S-1 you reference was for the 12% convertible notes and warrants.

And I don't think they are forbidden from selling shares in the open market until the loan is paid in full. I think they are forbidden from selling shares in the open market at a price lower than the conversion price until the loan is paid in full. Given that the conversion price is 75% of the price that the stock is trading, they are free to issue shares in the open market at the market price.

Quote:
The shelf registeration for the sep 30 financing of series H and 12% convertible notes was for about 9 mil shares. About 2.8 mil of those are in warrants convertible at $2. Taking the warrants aside, since it will be a while before the price gets high enough to convert, they can not convert more than 6.2 mil shares unless they do another shelf registration and have it approved by SEC. They still have to issue shares to make payments on the loan (principal + interest) until the loan is paid in full by sep 2016. The volume since Oct 15 is about 6.6 mil. In fact it is about 2.7 mil since 11/2, the day SEC issued a notice of effectiveness. So I think they are close to exhausting the convertible shares. Oh BTW, going forward AMBS is forbidden to sale shares in the open market until the loan is paid in full.



(0)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us